Measurement of the Clinical and Radiological Performance Impact of the Root Canal Treatment With BioRootTM RCS.
BioRoot RCS
1 other identifier
observational
142
1 country
9
Brief Summary
The aim of this retro-prospective Post-Market Clinical Follow-Up (PMCF) study is to collect long term clinical and safety data on root canal obturation after treatment, or retreatment, by BioRootTM RCS. The patients included in the study had received BioRootTM RCS 5 years ago. Participants will be followed prospectively at 5 and 10 years after root canal treatment. Clinical data, radiographic data, adverse events (safety) and device performance will be collected by the dentist from the inclusion visit until the end of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Longer than P75 for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 28, 2021
CompletedFirst Posted
Study publicly available on registry
February 18, 2022
CompletedStudy Start
First participant enrolled
February 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2029
ExpectedMay 6, 2026
April 1, 2026
3.7 years
December 28, 2021
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical and radiological performance impact of the endodontic treatment at 5 years.
The "success" and "failure" of the 5-year clinical and radiological performance impact of the endodontic treatment.
At 5 years post treatment
Secondary Outcomes (7)
Clinical and radiological performance impact of the endodontic treatment at 10 years.
At 10 years post treatment
Evaluation of the need of treatment or retreatment at 5 and 10 years.
At 5 and 10 Years post treatment
Assessment of the "tooth functional retention" at 5 and 10 years.
At 5 and 10 Years post treatment
The technical characteristics of the sealer BioRootTM RCS at 5 and 10 years after Root Canal Treatment.
At 5 and 10 Years post treatment
The ease of use and insertion of BioRootTM RCS in the canal.
At 5 years post treatment
- +2 more secondary outcomes
Interventions
BioRoot™ RCS is a hydrophilic mineral root canal sealer prepared from the mixture of a powder part and a liquid part. BioRoot™ RCS is a class III implantable medical device. This device is intended to be used in dentistry for permanent obturation of root canals of permanent and mature teeth with adjunction of gutta-percha points. Exposure to the sealer BioRootTM RCS starts from the day when the root canal treatment is performed until the end of individual observational period or the removal of the sealer in case of extraction or retreatment, if this event occurs before the end of individual observational period.
Eligibility Criteria
Patient in need of root canal treatment (or retreatment).
You may qualify if:
- Patient who had a non-surgical root canal treatment with BioRootTM RCS, in a context of an endodontic treatment, or retreatment, 5 years (± 6 months) ago.
- All roots of the investigational teeth were treated with BioRootTM RCS.
- Having a documented retro-alveolar radiography immediately after root canal obturation.
- Patient affiliated or beneficiary of a social security system.
- Patient has signed his/her informed consent form.
You may not qualify if:
- History of malignant tumors in the 5 years prior to the root canal treatment.
- Non-stabilized systemic disease during the month prior to the root canal treatment (diabetes, hypertension, thyroid disorders, etc.).
- Patient who developed a systemic pathology after the root canal treatment with BioRootTM RCS.
- The Root canal treatment with BioRootTM RCS is on a wisdom tooth.
- Tooth presenting an advanced periodontal disease (parodontal pocket ≥ 5mm or bone loss ≥ 50%).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Septodontlead
- EndoDatacollaborator
- Recherche Clinique en Odontologie (ReCOL)collaborator
Study Sites (9)
Cabinet Dentaire
Levallois-Perret, Perret, 92300, France
Cabinet dentaire
Dijon, 21000, France
Cabinet Dentaire
Muizon, 51140, France
Cabinet dentaire
Paris, 75006, France
Cabinet dentaire
Paris, 75009, France
Cabinet dentaire
Plérin, 22190, France
Cabinet dentaire
Saint-Amand-sur-Sèvre, 79700, France
Cabinet dentaire
Sézanne, 51120, France
Cabinet Medical
Villiers-sur-Marne, 94350, France
Study Officials
- STUDY DIRECTOR
Brigitte Grosgogeat, MD, PhD
CHU de Lyon, France
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 28, 2021
First Posted
February 18, 2022
Study Start
February 18, 2022
Primary Completion
November 7, 2025
Study Completion (Estimated)
July 1, 2029
Last Updated
May 6, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share